Kučera Matej, Hrabovská Anna
Ceska Slov Farm. 2015 Dec;64(6):254-63.
The cholinergic system of the heart can be either of neuronal or non-neuronal origin. The neuronal cholinergic system in the heart is represented by preganglionic parasympathetic pathways, intracardiac parasympathetic ganglia and postganglionic parasympathetic neurons projecting to the atria, SA node and AV node. The non-neuronal cholinergic system consists of cardiomyocytes that have complete equipment for synthesis and secretion of acetylcholine. Current knowledge suggests that the non-neuronal cholinergic system in the heart affects the regulation of the heart during sympathetic activation. The non-neuronal cholinergic system of the heart plays also a role in the energy metabolism of cardimyocites. Acetylcholine of both neuronal and non-neuronal origin acts in the heart through muscarinic and nicotinic receptors. The effect of acetylcholine in the heart is terminated by cholinesterases acetylcholinesterase and butyrylcholinesterase. Recently, papers suggest that the increased cholinergic tone in the heart by cholinesterase inhibitors has a positive effect on some cardiovascular disorders such as heart failure. For this reason, the cholinesterase inhibitors might be used in the treatment of certain cardiovascular disorders in the future.
心脏的胆碱能系统可以起源于神经元或非神经元。心脏中的神经元胆碱能系统由节前副交感神经通路、心内副交感神经节以及投射至心房、窦房结和房室结的节后副交感神经元代表。非神经元胆碱能系统由具备合成和分泌乙酰胆碱全套机制的心肌细胞组成。目前的知识表明,心脏中的非神经元胆碱能系统在交感神经激活期间影响心脏的调节。心脏的非神经元胆碱能系统在心肌细胞的能量代谢中也发挥作用。源自神经元和非神经元的乙酰胆碱通过毒蕈碱受体和烟碱受体在心脏中发挥作用。心脏中乙酰胆碱的作用由胆碱酯酶乙酰胆碱酯酶和丁酰胆碱酯酶终止。最近,有论文表明,胆碱酯酶抑制剂增加心脏中的胆碱能张力对某些心血管疾病如心力衰竭有积极作用。因此,胆碱酯酶抑制剂未来可能用于治疗某些心血管疾病。